Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

VIN MED MERE.DK ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 4.1% 4.1%   Bankruptcy risk   3.2% 1.7% 1.3% 0.7% 0.9% 0.6% 6.1% 5.9%   Credit score (0-100)   57 74 80 95 90 96 38 39   Credit rating   BBB A A AA A AA BBB BBB   Credit limit (kDKK)   0.0 4.1 155.3 1,236.7 674.5 1,086.8 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,438 5,131 11,244 16,834 12,773 12,270 0.0 0.0   EBITDA   408 2,108 5,199 6,569 3,150 5,226 0.0 0.0   EBIT   230 1,916 4,903 6,171 2,543 4,725 0.0 0.0   Pre-tax profit (PTP)   226.1 1,908.3 4,873.5 5,931.9 2,142.4 4,139.5 0.0 0.0   Net earnings   174.4 1,488.3 3,801.3 4,579.4 1,624.6 3,260.0 0.0 0.0   Pre-tax profit without non-rec. items   226 1,908 4,874 5,932 2,142 4,139 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   662 847 1,146 847 360 321 0.0 0.0   Shareholders equity total   667 1,955 4,956 7,036 5,160 6,820 3,540 3,540   Interest-bearing liabilities   25.1 374 3,204 4,205 10,875 4,923 0.0 0.0   Balance sheet total (assets)   2,764 4,905 16,778 20,023 22,679 16,578 3,540 3,540   Net Debt   -322 144 2,357 4,082 10,807 4,898 -2,218 -2,218     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,438 5,131 11,244 16,834 12,773 12,270 0.0 0.0   Gross profit growth   -27.4% 110.4% 119.1% 49.7% -24.1% -3.9% -100.0% 0.0%   Employees   3 7 17 28 23 16 0 0   Employee growth %   -25.0% 133.3% 142.9% 64.7% -17.9% -30.4% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,764 4,905 16,778 20,023 22,679 16,578 3,540 3,540   Balance sheet change%   2.7% 77.5% 242.0% 19.3% 13.3% -26.9% -78.6% 0.0%   Added value   407.7 2,107.7 5,199.3 6,568.6 2,939.9 5,226.5 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -222 -6 2 174 -281 -901 -321 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   9.4% 37.3% 43.6% 36.7% 19.9% 38.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   8.4% 50.0% 45.2% 33.5% 11.9% 24.1% 0.0% 0.0%   ROI %   20.5% 123.3% 92.2% 62.5% 18.2% 33.2% 0.0% 0.0%   ROE %   16.2% 113.5% 110.0% 76.4% 26.6% 54.4% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   24.1% 39.9% 29.5% 35.1% 22.8% 41.1% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -78.9% 6.8% 45.3% 62.1% 343.1% 93.7% 0.0% 0.0%   Gearing %   3.8% 19.1% 64.6% 59.8% 210.7% 72.2% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   14.6% 3.7% 1.6% 6.5% 5.3% 7.4% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.4 0.2 0.2 0.1 0.1 0.1 0.0 0.0   Current Ratio   0.9 1.3 1.3 1.4 1.2 1.6 0.0 0.0   Cash and cash equivalent   346.8 230.2 846.6 122.6 67.9 24.6 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -116.3 804.3 3,523.0 5,275.5 3,189.1 5,308.2 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   136 301 306 235 128 327 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   136 301 306 235 137 327 0 0   EBIT / employee   77 274 288 220 111 295 0 0   Net earnings / employee   58 213 224 164 71 204 0 0